[1]
Lu, H., Meyer, P. and Hullin, R. 2020. Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how? A narrative literature review. Swiss Medical Weekly. 150, 3536 (Sep. 2020), w20341. DOI:https://doi.org/10.4414/smw.2020.20341.